We are live on ! Find out more

1,565 hedge funds and large institutions have $109B invested in Merck in 2013 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 581 increasing their positions, 627 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 70

46% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $953M

7% more funds holding

Funds holding: 1,4691,565 (+96)

6% more capital invested

Capital invested by funds: $103B → $109B (+$5.89B)

0.21% more ownership

Funds ownership: 77.81%78.01% (+0.21%)

7% less repeat investments, than reductions

Existing positions increased: 581 | Existing positions reduced: 627

3% less funds holding in top 10

Funds holding in top 10: 117113 (-4)

Holders
1,565
Holders Change
+96
Holders Change %
+6.54%
% of All Funds
45.43%
Holding in Top 10
113
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-3.42%
% of All Funds
3.28%
New
187
Increased
581
Reduced
627
Closed
70
Calls
$1.39B
Puts
$953M
Net Calls
+$434M
Net Calls Change
+$103M
Name Holding Trade Value Shares
Change
Change in
Stake
HI
176
Honeywell International
North Carolina
$65.1M +$2.3M +50,304 +4%
Bessemer Group
177
Bessemer Group
New Jersey
$64.7M +$17.2M +376,700 +38%
Nisa Investment Advisors
178
Nisa Investment Advisors
Missouri
$62.6M -$3.38M -73,860 -5%
Lord, Abbett & Co
179
Lord, Abbett & Co
New Jersey
$60.7M +$5.94M +129,902 +11%
IRF
180
IBM Retirement Fund
New York
$60.5M -$1.99M -43,608 -3%
Janus Henderson Group
181
Janus Henderson Group
United Kingdom
$60.4M -$409K -8,941 -0.7%
TGI
182
Tradewinds Global Investors
California
$60.4M +$495K +10,824 +0.9%
GT
183
Glenmede Trust
Pennsylvania
$60M -$905K -19,805 -2%
TRSOTSOK
184
Teachers Retirement System of the State of Kentucky
Kentucky
$59.5M -$3.87M -84,574 -6%
OAC
185
OMERS Administration Corp
Ontario, Canada
$59.3M +$42M +918,153 +285%
CB
186
Commerce Bank
Missouri
$58.8M -$119K -2,608 -0.2%
EA
187
Euclid Advisors
Connecticut
$58.7M -$2.75M -60,155 -5%
CCMH
188
Cornerstone Capital Management Holdings
New York
$58.3M +$10M +218,883 +22%
ACI
189
AMP Capital Investors
Australia
$58.3M -$2.46M -53,832 -4%
MSA
190
Mason Street Advisors
Wisconsin
$58M +$8.89M +194,448 +19%
FMI
191
Factory Mutual Insurance
Massachusetts
$57.9M -$1.92M -41,920 -3%
DekaBank Deutsche Girozentrale
192
DekaBank Deutsche Girozentrale
Germany
$57.8M -$6.14M -134,328 -10%
KBC Group
193
KBC Group
Belgium
$56.7M +$6.23M +136,341 +13%
GF
194
Gabelli Funds
New York
$55.8M +$311K +6,812 +0.6%
Calamos Advisors
195
Calamos Advisors
Illinois
$55.2M -$36.8M -805,510 -41%
Fisher Asset Management
196
Fisher Asset Management
Washington
$55.1M +$10.3K +225 +0%
SAM
197
Sectoral Asset Management
Quebec, Canada
$54.8M +$4.4M +96,358 +9%
Public Sector Pension Investment Board (PSP Investments)
198
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$54.4M +$5.33M +116,537 +11%
HCM
199
Hamlin Capital Management
New York
$52.4M +$2.09M +45,617 +4%
HEIP
200
Hudson Edge Investment Partners
New Jersey
$52.3M -$172K -3,762 -0.3%

MRK Hedge Fund Activity: Q4 2013 in Review

1,565 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2013, worth a combined $109B — up 5.7% from $103B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 70 closed out — a net gain of 117 holders — while 581 added to existing stakes and 627 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Fidelity Investments, cutting an estimated $386M.

  • 1,565 institutional investors held Merck (MRK) as of Q4 2013, up from 1,469 in Q3 2013.
  • Funds reported $109B of Merck stock for Q4 2013, up 5.7% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q4 2013 and 70 closed out, a net change of +117 holders.
  • The largest Merck buyer in Q4 2013 was Capital World Investors, an estimated $561M added.
  • The largest Merck seller in Q4 2013 was Fidelity Investments, an estimated $386M sold.

Based on aggregated 13F filings for Q4 2013.